Acme United (ACU) Q2 2026 Earnings: EPS Beats Estimates, Margin Expansion Driven by Acquisitions

• Acme United (ACU) reported second-quarter 2026 earnings per share of $1.22, significantly surpassing the $0.81 consensus estimate by 50.62%.
• Revenue reached $62.7 million, beating the $58.1 million forecast, driven by a 16% year-over-year sales increase.
• The company expanded gross margins to 42.6% from 41.0% in the prior year period, signaling improved operational efficiency.
• Investors should monitor elevated SG&A expenses at 32% of sales and ongoing tariff pressures as key risk factors.

Acme United Corporation (ACU) delivered robust second-quarter 2026 financial results, significantly outperforming analyst expectations across both the top and bottom lines. Earnings per share reached $1.22 against a forecast of $0.81, representing a substantial 50.62% surprise for market participants. This performance triggered an 11.92% share price surge, bringing the stock near its 52-week high of $51.88. The positive reaction underscores investor confidence in the company's strategic pivot and acquisition integration.

Revenue also exceeded expectations, posting $62.7 million compared to the $58.1 million estimate, a 7.99% upside. The top-line growth was robust, with sales rising 16% year-over-year. This performance was largely attributed to the integration of the MyMedic acquisition. Excluding acquisition effects, organic growth stood at 8%, indicating underlying business momentum beyond inorganic expansion.

How Is the MyMedic Acquisition Driving Growth?

The integration of the MyMedic acquisition has been a primary catalyst for Acme United's recent performance. Management highlighted that the integration is progressing well, with strategic efforts to expand the brand from direct-to-consumer channels into mass retail. This expansion into broader distribution channels is expected to unlock further value for the MyMedic brand in the coming quarters.

Chief Executive Officer Johnsen provided forward-looking commentary, expecting continued margin recovery through the remainder of the year. This trajectory is supported by the replacement of higher-tariff inventory with lower-cost stock as tariff pressures diminish. The company anticipates strong profitability in the fourth quarter, driven by seasonal demand. The strategic focus on mass retail distribution for MyMedic is expected to complement the existing direct-to-consumer model, diversifying revenue streams.

What Is the Outlook for Margin Recovery and Tariffs?

Gross margins expanded notably to 42.6% from 41.0% in the prior year period, indicating improved operational efficiency or pricing power. CEO Johnsen indicated that margin recovery will continue as tariff pressures ease. The company is actively replacing higher-tariff inventory with lower-cost stock throughout the year. This proactive inventory management is critical to sustaining the margin expansion observed in Q2.

However, selling, general, and administrative (SG&A) expenses remain elevated at 32% of sales. This elevated cost structure presents a challenge to overall profitability, even as gross margins improve. Additional headwinds include ongoing tariff and freight costs, potential currency fluctuations, and uneven geographic performance. Investors should monitor how effectively management can control SG&A expenses while navigating these external cost pressures.

What Are the Key Risks and Geographic Headwinds?

Despite the positive outlook, investors should note key risks identified in the report. Geographic performance was uneven, with Canada currently lagging other regions. This regional disparity suggests potential challenges in the Canadian market that require strategic attention. The company's ability to stabilize performance in Canada will be a key metric for future success.

Additional headwinds include ongoing tariff and freight expenses, which could impact future margins if not managed effectively. Currency volatility also poses a risk to international operations, particularly in regions with fluctuating exchange rates. The combination of elevated SG&A costs and external macroeconomic factors creates a complex operating environment. Acme United's ability to navigate these challenges will determine the sustainability of its current growth trajectory.

The company's strategic focus on margin recovery and acquisition integration provides a positive outlook for medium-term profitability. However, the elevated cost structure and geographic disparities present near-term challenges that investors should carefully evaluate. The upcoming fourth quarter will be critical in assessing the effectiveness of the company's tariff mitigation strategies and mass retail expansion efforts.